126 related articles for article (PubMed ID: 1816578)
21. Irreversible suppression of alcohol drinking in cyanamide-treated rats after sustained delivery of the 5-HT2 antagonist amperozide.
Myers RD; Lankford M; Björk A
Alcohol; 1993; 10(2):117-25. PubMed ID: 8442888
[TBL] [Abstract][Full Text] [Related]
22. Naltrexone suppresses ethanol intake in 6-hydroxydopamine-treated rats.
Koistinen M; Tuomainen P; Hyytiä P; Kiianmaa K
Alcohol Clin Exp Res; 2001 Nov; 25(11):1605-12. PubMed ID: 11707635
[TBL] [Abstract][Full Text] [Related]
23. 6-OHDA-lesions of the nucleus accumbens disrupt the acquisition but not the maintenance of ethanol consumption in the alcohol-preferring P line of rats.
Ikemoto S; McBride WJ; Murphy JM; Lumeng L; Li TK
Alcohol Clin Exp Res; 1997 Sep; 21(6):1042-6. PubMed ID: 9309315
[TBL] [Abstract][Full Text] [Related]
24. Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment.
Brus R; Kostrzewa RM; Perry KW; Fuller RW
J Pharmacol Exp Ther; 1994 Jan; 268(1):231-7. PubMed ID: 8301563
[TBL] [Abstract][Full Text] [Related]
25. Failure of the 5-HT2 receptor antagonist, ritanserin, to alter preference for alcohol in drinking rats.
Myers RD; Lankford MF
Pharmacol Biochem Behav; 1993 May; 45(1):233-7. PubMed ID: 8516364
[TBL] [Abstract][Full Text] [Related]
26. Role of serotonin receptors in the effect of sertraline on feeding behaviour.
Grignaschi G; Samanin R
Psychopharmacology (Berl); 1993; 110(1-2):203-8. PubMed ID: 7870886
[TBL] [Abstract][Full Text] [Related]
27. Differential efficacy of serotonergic drugs FG5974, FG5893, and amperozide in reducing alcohol drinking in P rats.
Lankford MF; Björk AK; Myers RD
Alcohol; 1996; 13(4):399-404. PubMed ID: 8836330
[TBL] [Abstract][Full Text] [Related]
28. Buspirone alters alcohol drinking induced in rats by tetrahydropapaveroline injected into brain monoaminergic pathways.
Privette TH; Hornsby RL; Myers RD
Alcohol; 1988; 5(2):147-52. PubMed ID: 3395461
[TBL] [Abstract][Full Text] [Related]
29. Neonatal treatment with 5,7-dihydroxytryptamine induces decrease in alcohol drinking in adult animals.
Jessa M; Krzaścik P; Kostowski W
Pol J Pharmacol; 2001; 53(2):109-16. PubMed ID: 11787949
[TBL] [Abstract][Full Text] [Related]
30. Serotonin and alcohol drinking.
Sellers EM; Higgins GA; Tompkins DM; Romach MK
NIDA Res Monogr; 1992; 119():141-5. PubMed ID: 1435969
[No Abstract] [Full Text] [Related]
31. Effects of 5,7-dihydroxytryptamine lesions of the nucleus accumbens on rat intravenous morphine self-administration.
Smith JE; Shultz K; Co C; Goeders NE; Dworkin SI
Pharmacol Biochem Behav; 1987 Mar; 26(3):607-12. PubMed ID: 3575377
[TBL] [Abstract][Full Text] [Related]
32. Association between low contents of dopamine and serotonin in the nucleus accumbens and high alcohol preference.
McBride WJ; Bodart B; Lumeng L; Li TK
Alcohol Clin Exp Res; 1995 Dec; 19(6):1420-2. PubMed ID: 8749804
[TBL] [Abstract][Full Text] [Related]
33. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
Koe BK; Weissman A; Welch WM; Browne RG
J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
[TBL] [Abstract][Full Text] [Related]
34. Enhanced quinpirole response in rats lesioned neonatally with 5,7-dihydroxytryptamine.
Brus R; Plech A; Kostrzewa RM
Pharmacol Biochem Behav; 1995 Apr; 50(4):649-53. PubMed ID: 7617714
[TBL] [Abstract][Full Text] [Related]
35. Mmu and D2 receptor antisense oligonucleotides injected in nucleus accumbens suppress high alcohol intake in genetic drinking HEP rats.
Myers RD; Robinson DE
Alcohol; 1999; 18(2-3):225-33. PubMed ID: 10456575
[TBL] [Abstract][Full Text] [Related]
36. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
37. Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of beta-adrenoceptor system of rat brain.
Koe BK; Koch SW; Lebel LA; Minor KW; Page MG
Eur J Pharmacol; 1987 Sep; 141(2):187-94. PubMed ID: 2824215
[TBL] [Abstract][Full Text] [Related]
38. Sertraline, a serotonin-uptake inhibitor, reduces food intake and body weight in lean rats and genetically obese mice.
Nielsen JA; Chapin DS; Johnson JL; Torgersen LK
Am J Clin Nutr; 1992 Jan; 55(1 Suppl):185S-189S. PubMed ID: 1728832
[TBL] [Abstract][Full Text] [Related]
39. Lesioning of midbrain raphe nuclei with 5,7-DHT fails to alter ethanol intake in the low alcohol drinking (LAD) rat.
Adell A; Myers RD
Prog Neuropsychopharmacol Biol Psychiatry; 1996 Apr; 20(3):473-81. PubMed ID: 8771602
[TBL] [Abstract][Full Text] [Related]
40. Sertraline: a new specific serotonin reuptake blocker.
Guthrie SK
DICP; 1991 Sep; 25(9):952-61. PubMed ID: 1949975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
